Modeling Shows NS5A Inhibitor Has Two Modes of Action in HCV
The field of hepatitis C virus (HCV) research is hot. So hot, in fact, that in January the BioWorld Today staff ranked the unfolding story of the exceptional performance of HCV potential treatments from the clinic in second place in the top 10 most impactful stories of last year. (See BioWorld Today, Jan. 2, 2013.)
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST